Publications

View Dr. Peacock’s Publications

Publications on PubMed

Recent publications from the CanSURVIVE Research Group are listed below.

The impact of the COVID-19 pandemic on health-related quality of life of cancer patients in British Columbia. Journal of Patient-Reported Outcomes 2024 

Izadi-Najafabadi S, McTaggart-Cowan H, Halperin R, Lambert L, Mitton C, Peacock S. | 2024 Aug 23;8(1):100. doi: 10.1186/s41687-024-00759-z. PMID: 39177926; PMCID: PMC11343924.

Development of a Value Assessment Framework for Pediatric Health Technologies Using Multicriteria Decision Analysis: Expanding the Value Lens for Funding Decision Making. Value in Health 2024. 

Gauvreau CL, Schreyer L, Gibson PJ, Koo A, Ungar WJ, Regier D, Chan K, Hayeems R, Gibson J, Palmer A, Peacock S, Denburg AE. | Mar 27:S1098-3015(24)00127-X. doi: 10.1016/j.jval.2024.03.012. Epub ahead of print. PMID: 38548179.

Meaningful patient engagement in adolescent and young adult (AYA) cancer research: A framework for qualitative studies. Current Oncology 2024

Oveisi N, Cheng V, Taylor D, Bechthold H, Bar nes M, Jansen N, McTaggart-Cowan H, Brotto LA, Peacock S, Hanley GE, Gill S, Rayar M, Srikanthan A, De Vera MA. | Curr Oncol. 2024 Mar 22;31(4):1689-1700. doi: 10.3390/curroncol31040128. PMID: 38668031; PMCID: PMC11049004.

Strategies to accelerate the elimination of cervical cancer in British Columbia: Canada: a modelling study. Canadian Medical Association Journal 2024 

Pataky RE, Izadi-Najafabadi S, Smith LW, Gottschlich A, Ionescu D, Proctor L, Ogilvie GS, Peacock S. | CMAJ. 2024 Jun 2;196(21):E716-E723. doi: 10.1503/cmaj.231682. PMID: 38830680; PMCID: PMC11142038.

Real-world cost-effectiveness of a policy of KRAS testing to inform cetuximab or panitumumab for third-line therapy of metastatic colorectal cancer in British Columbia, Canada. Pharmacoecon Open 2023

Pataky RE, Bryan S, Sadatsafavi M, Peacock S, Regier DA. | Pharmacoecon Open 2023. Nov;7(6):997-1006. doi: 10.1007/s41669-023-00444-9. 

Sexual health outcomes among adolescent and young adult cancer patients: a systematic review and meta-analysis. JNCI Cancer Spectr. 2023 

Oveisi N, Cheng V, Brotto LA, Peacock S, McTaggart-Cowan H, Hanley G, Gill S, Rayar M, Srikanthan A, Ellis U, De Vera MA. | JNCI Cancer Spectr. 2023 Oct 31;7(6):pkad087. doi: 10.1093/jncics/pkad087. PMID: 37878813; PMCID: PMC10674049.

Reproductive Health Outcomes among Adolescent and Young Adult Cancer Patients: A Systematic Review and Meta-Analysis. 

Oveisi N, Cheng V, Ellis U, Peacock S, McTaggart-Cowan H, Brotto LA, Loree J, Hanley GE, Gill S, Rayar M, Srikanthan A, De Vera MA | Cancers 2023; 15: 1707. https://doi.org/10.3390/cancers15061707.

Development of a Multi-Criteria Decision Analysis Rating Tool to Prioritize Real-World Evidence Questions for the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration. Current Oncology 2023.

Parmar A, Dai WF, Dionne F, Geirnaert M, Denburg A, Ahuja T, Beca J, Bouchard S, Chambers C, Hunt MJ, Husereau D, Lungu E, McDonald V, Mercer RE, Mitera G, Muñoz C, Naipaul R, Peacock S, Potashnik T, Tadrous M, Takhar P, Taylor M, Trudeau M, Wasney D, Gavura S, Chan KKW. | Mar 28;30(4):3776-3786. doi: 10.3390/curroncol30040286. PMID: 37185399; PMCID: PMC10137247. 

Direct medical costs of young-onset colorectal cancer: A worldwide systematic review. 

Garg R, Cheng V, Ellis U, Verma V, McTaggart-Cowan H, Peacock S, Loree JM, Sadatsafavi M, De Vera M. | BMC Health Services Research 2022 Aug 30;22(1):1100. doi: 10.1186/s12913-022-08481-6. PMID: 36042470.

Risk of anxiety and depression after diagnosis of young-onset colorectal cancer: A population-based cohort study. 

Howren A, Sayre EC, Cheng V, Oveisi N, McTaggart-Cowan H, Peacock S, De Vera MA. | Current Oncology 2022 Apr 27;29(5):3072-3081. doi: 10.3390/curroncol29050249. PMID: 35621639; PMCID: PMC9140150.